Total Visits

Views
Multicenter Phase 2 Trial of Rituximab for Waldenström Macroglobulinemia (WM): An Eastern Cooperative Oncology Group Study (E3A98)203

Total Visits Per Month

May 2022June 2022July 2022August 2022September 2022October 2022November 2022
Multicenter Phase 2 Trial of Rituximab for Waldenström Macroglobulinemia (WM): An Eastern Cooperative Oncology Group Study (E3A98)5344511

File Visits

Views
009163.pdf1
009163.pdf1

Top country views

Views
United States123
Germany28
Sweden10
Spain4
Slovenia3
Italy2
Ukraine2
Canada1
China1
EU1

Top cities views

Views
Woodbridge35
Fairfield25
Kiez22
Houston18
Wilmington17
Cambridge8
Ilmenau5
Ann Arbor3
Chicago3
Jacksonville3